Approaches and Metrics in Fraily Patients During COVID-19 Era

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

December 22, 2020

Primary Completion Date

February 15, 2021

Study Completion Date

November 23, 2022

Conditions
FrailtyOncologyImmune Deficiency
Interventions
OTHER

Collecting biological material from frail patients, with or without COVID-19

The study planned to collect demographic information, disease history, COVID-19 symptomatology, COVID-19 molecular test details, COVID-19 serological test results, and biobanking of biological specimens (PBMCs, sera, plasma). In addition, clinical analyses, anamnestic data, and pharmacological treatment pieces of information were collected.

Trial Locations (2)

00144

"Regina Elena National Cancer Institute", Rome

Regina Elena Cancer Institute, Rome

All Listed Sponsors
lead

Regina Elena Cancer Institute

OTHER

NCT05792891 - Approaches and Metrics in Fraily Patients During COVID-19 Era | Biotech Hunter | Biotech Hunter